Adamas Pharmaceuticals, Inc. Gains 44.83%

Fri 07 Aug 20 at 05:30 PM
Adamas Pharmaceuticals, Inc. Gains 44.83%

Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ) soared at $3.78, representing a gain of 44.8%. On Thu 06 Aug 20, ADMS:NASDAQ hit a New 2-Week Intraday High of $2.67. The stock got featured on our News Catalysts scanner on Thu 06 Aug 20 at 04:41 PM in the 'EARNINGS' category. From Thu 23 Jul 20, the stock recorded 40.00% Up Days and 27.27% Green Days

The share price of the company has been moving sideways in recent weeks.

About Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ)

Adamas Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The Company is developing its wholly-owned product candidate, ADS-5102.